Matches in Nanopublications for { ?s ?p "[JAK1/2 inhibitors have broadened the therapeutic options in myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[JAK1/2 inhibitors have broadened the therapeutic options in myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[JAK1/2 inhibitors have broadened the therapeutic options in myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1217006.RARovEh7o5VWk_9OwyjGjkOKGO_jc3_TcvtUdoAFZ4VHY130_assertion description "[JAK1/2 inhibitors have broadened the therapeutic options in myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217006.RARovEh7o5VWk_9OwyjGjkOKGO_jc3_TcvtUdoAFZ4VHY130_provenance.
- NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_assertion description "[JAK1/2 inhibitors have broadened the therapeutic options in myelofibrosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217007.RAhpQKOw0Vg6ZsKjmUpf4063uFCtmdiJ2jpEKepBhcvYw130_provenance.